Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Timothy Fleming"'
Autor:
Sandhya Bansal, Ashwini Arjuna, Brian Franz, Alexa Guerrero-Alba, Jesse Canez, Timothy Fleming, Mohammad Rahman, Ramsey Hachem, T. Mohanakumar
Publikováno v:
Frontiers in Transplantation, Vol 2 (2023)
Identification of recipients with pre-existing antibodies and cross-matching of recipient sera with donor lymphocytes have reduced the incidence of antibody-mediated rejection (AMR) after human lung transplantation. However, AMR is still common and r
Externí odkaz:
https://doaj.org/article/35c1f5a86c7a47948d2dfa3e3f79aef3
Autor:
Ranjithkumar Ravichandran, Sandhya Bansal, Mohammad Rahman, Angara Sureshbabu, Narendra Sankpal, Timothy Fleming, Ankit Bharat, Thalachallour Mohanakumar
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Transplantation is a treatment option for patients diagnosed with end-stage organ diseases; however, long-term graft survival is affected by rejection of the transplanted organ by immune and nonimmune responses. Several studies have demonstrated that
Externí odkaz:
https://doaj.org/article/58a43e4b0c2b4eaeb2ad5c8aeb2dbb40
Autor:
Sandhya Bansal, Sofya Tokman, Timothy Fleming, Gabriel N. Maine, Kristina Sanborn, Ramsey Hachem, Ankit Bharat, Michael A. Smith, Ross M. Bremner, T. Mohanakumar
Publikováno v:
Clinical and Translational Medicine, Vol 11, Iss 11, Pp n/a-n/a (2021)
Externí odkaz:
https://doaj.org/article/d4b24f25176c4b6ba420d34fe261aaf5
Autor:
Ranjithkumar Ravichandran, Yoshihiro Itabashi, Timothy Fleming, Sandhya Bansal, Sara Bowen, Christin Poulson, Ankit Bharat, Ross Bremner, Michael Smith, Thalachallour Mohanakumar
Publikováno v:
American Journal of Transplantation. 22:2180-2194
To determine the effects and immunological mechanisms of low-dose interleukin-2 (IL-2) in a murine model of chronic cardiac allograft rejection (BALB/c to C57BL/6) after costimulatory blockade consisting of MR1 (250 μg/ip day 0) and CTLA4-Ig (200 μ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e87d917a5a4b64566b53afb2ceb561f
https://doi.org/10.1111/ajt.17101
https://doi.org/10.1111/ajt.17101
Autor:
William E. Gillanders, Thalachallour Mohanakumar, Peter Goedegebuure, Timothy Fleming, Feng Gao, A. Craig Lockhart, Michael Naughton, Cynthia Ma, Matthew Ellis, Mark Sturmoski, Lijin Li, John Herndon, Natalia Tucker, Venkataswarup Tiriveedhi
Purpose: Mammaglobin-A (MAM-A) is overexpressed in 40% to 80% of primary breast cancers. We initiated a phase I clinical trial of a MAM-A DNA vaccine to evaluate its safety and biologic efficacy.Experimental Design: Patients with breast cancer with s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0565022047764e93a698dc910289030f
https://doi.org/10.1158/1078-0432.c.6523055.v1
https://doi.org/10.1158/1078-0432.c.6523055.v1
Autor:
William E. Gillanders, Thalachallour Mohanakumar, Peter Goedegebuure, Timothy Fleming, Feng Gao, A. Craig Lockhart, Michael Naughton, Cynthia Ma, Matthew Ellis, Mark Sturmoski, Lijin Li, John Herndon, Natalia Tucker, Venkataswarup Tiriveedhi
Supplementary Figure 1: Expression of MAM-A and HLA-A2 in breast cancer cell lines. Supplementary Figure 2: MAM-A DNA vaccination increases breast cancer-induced TNF-α production by MAM-A-specific CD8 T cells. Supplementary Figure 3: MAM-A DNA vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f2cc012c0099a26be350830da3640bc
https://doi.org/10.1158/1078-0432.22455551
https://doi.org/10.1158/1078-0432.22455551
Autor:
Mohammad Rahman, Ranjithkumar Ravichandran, Narendra V. Sankpal, Sandhya Bansal, Angara Sureshbabu, Timothy Fleming, Sudhir Perincheri, Ankit Bharat, Michael A. Smith, Ross M. Bremner, T. Mohanakumar
Publikováno v:
Cellular Immunology. 386:104690
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce2322a65c2690d7768e3e51d9aabf76
https://doi.org/10.1016/j.cellimm.2023.104690
https://doi.org/10.1016/j.cellimm.2023.104690
Autor:
Chiahsuan Chin, Ranjithkumar Ravichandran, Kristina Sanborn, Timothy Fleming, Stephen B. Wheatcroft, Mark T. Kearney, Sofya Tokman, Rajat Walia, Michael A. Smith, David J. Flint, Thalachallour Mohanakumar, Ross M. Bremner, Angara Sureshbabu
Publikováno v:
Cell Reports Medicine. 4:100945
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c05b6b04094fc6142786046171178428
https://doi.org/10.1016/j.xcrm.2023.100945
https://doi.org/10.1016/j.xcrm.2023.100945
Publikováno v:
The Journal of Immunology. 208:1833-1834
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b45cec9b6f2fb432c23a87d0f77f905
https://doi.org/10.4049/jimmunol.2101067
https://doi.org/10.4049/jimmunol.2101067
Autor:
Sumeet K. Mittal, Thalachallour Mohanakumar, Timothy Fleming Ph.D., John Lee, R. Bremner, Rongbing Chen
Publikováno v:
OncoTargets and therapy
John Lee, Rongbing Chen, T Mohanakumar, Ross Bremner, Sumeet Mittal, Timothy P Fleming Norton Thoracic Institute, St. Joseph Hospital, Phoenix, AZ, USACorrespondence: Timothy P FlemingSt. Joseph’s Hospital and Medical Center, Norton Thoracic Instit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1200e19d27b348a9f8f7e2867e392181
https://www.dovepress.com/identification-of-phospho-tyrosine-targets-as-a-strategy-for-the-treat-peer-reviewed-fulltext-article-OTT
https://www.dovepress.com/identification-of-phospho-tyrosine-targets-as-a-strategy-for-the-treat-peer-reviewed-fulltext-article-OTT